Lyra Therapeutics Growth Metrics (2021-2025) | LYRA

Growth Metrics Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Growth Ratios
EBITDA Margin Growth (1y) 7.49M-12.43M-0.14M-0.07M0.12M11.90M-0.03M-0.46M-0.32M1.12M-0.04M0.40M-1.79M
EBITDA Margin Growth (3y) 7.29M0.59M-0.21M-0.13M-1.98M
EBITDA Margin (QoQ) 7.39M0.25M-0.02M-0.14M-12.52M12.53M0.06M0.05M-0.75M0.61M-0.38M0.20M0.69M-0.55M0.06M-1.99M
EBIT Margin Growth (1y) 7.50M-13.27M-0.17M-0.09M0.10M12.65M-0.02M-0.46M-0.33M1.21M-0.04M0.34M-1.86M
EBIT Margin Growth (3y) 7.28M0.59M-0.23M-0.21M-2.08M
EBIT Margin (QoQ) 7.41M0.25M-0.02M-0.14M-13.36M13.36M0.06M0.05M-0.82M0.69M-0.38M0.18M0.72M-0.57M820.00-2.01M
EBT Margin Growth (1y) 7.49M-12.43M-0.14M-0.07M0.12M11.89M-0.03M-0.46M-0.32M1.12M-0.05M0.40M-1.78M
EBT Margin Growth (3y) 7.29M0.59M-0.21M-0.13M-1.98M
EBT Margin (QoQ) 7.39M0.25M-0.02M-0.14M-12.52M12.53M0.06M0.05M-0.75M0.62M-0.38M0.20M0.69M-0.55M0.06M-1.99M
Enterprise Value Growth (1y) 48.44%-77.30%-91.47%-115.48%-146.78%3.97%6.62%-4.89%-5.94%40.88%48.42%61.04%64.39%57.12%58.78%
Enterprise Value Growth (3y) -10.47%-0.22%2.66%4.15%2.35%37.56%41.66%
Enterprise Value (QoQ) -4.45%15.81%20.74%26.03%-259.16%9.08%10.80%15.28%-39.76%11.58%-0.20%14.44%22.01%22.85%24.32%21.79%6.10%25.84%
FCF Margin Growth (1y) 7.43M-10.63M-0.13M-0.15M0.04M9.72M-0.07M-0.02M-0.57M1.44M-0.02M-0.02M-2.13M
FCF Margin Growth (3y) 6.90M0.54M-0.23M-0.20M-2.66M
FCF Margin (QoQ) 7.28M0.20M0.09M-0.14M-10.78M10.70M0.07M0.05M-1.10M0.90M0.13M-0.50M0.92M-0.57M0.12M-2.60M
Net Margin Growth (1y) 7.49M-12.43M-0.14M-0.07M0.12M11.89M-0.03M-0.46M-0.32M1.12M-0.05M0.40M-1.78M
Net Margin Growth (3y) 7.29M0.59M-0.21M-0.13M-1.98M
Net Margin (QoQ) 7.39M0.25M-0.02M-0.14M-12.52M12.53M0.06M0.05M-0.75M0.62M-0.38M0.20M0.69M-0.55M0.06M-1.99M
Operating Margin Growth (1y) 7.50M-13.27M-0.17M-0.09M0.10M12.65M-0.02M-0.46M-0.33M1.21M-0.04M0.34M-1.86M
Operating Margin Growth (3y) 7.28M0.59M-0.23M-0.21M-2.08M
Operating Margin (QoQ) 7.41M0.25M-0.02M-0.14M-13.36M13.36M0.06M0.05M-0.82M0.69M-0.38M0.18M0.72M-0.57M820.00-2.01M
Return on Assets Growth (1y) 23.0035.002.00-6.001.0010.00-30.00-62.00-81.00-81.0015.0044.00
Return on Assets Growth (3y) -58.00-36.00-14.00-25.00
Return on Assets (QoQ) -22.0036.0014.00-4.00-10.003.005.003.00-1.00-37.00-27.00-16.00-1.0058.003.00
Return on Capital Employed Growth (1y) 45.0093.00-1.00-14.00-4.0011.00-40.00-78.00-101.00-104.0011.0050.00
Return on Capital Employed Growth (3y) -60.000.00M-31.00-42.00
Return on Capital Employed (QoQ) -62.0098.0016.00-7.00-14.004.003.003.000.00M-48.00-34.00-19.00-3.0068.005.00
Return on Equity Growth (1y) 43.0084.005.00-13.00-9.00-1.00-113.00-311.00-508.00-946.00-0.00M0.00M
Return on Equity Growth (3y) -473.00-863.00-0.00M0.00M
Return on Equity (QoQ) -59.0087.0024.00-9.00-18.007.006.00-5.00-10.00-104.00-191.00-202.00-448.00-385.000.00M
Return on Invested Capital Growth (1y) -521.00-969.00-0.00M0.00M
Return on Invested Capital (QoQ) -11.00-107.00-198.00-205.00-458.00-456.000.00M
Return on Sales Growth (1y) 0.07M-0.12M-0.00M-674.000.00M0.12M-256.00-0.00M-0.00M0.01M-450.000.00M-0.02M
Return on Sales Growth (3y) 0.07M0.01M-0.00M-0.00M-0.02M
Return on Sales (QoQ) 0.07M0.00M-191.00-0.00M-0.13M0.13M555.00533.00-0.01M0.01M-0.00M0.00M0.01M-0.01M607.00-0.02M